Mandate

Vinge has advised Bilprovningen in connection with the disposal of Besiktningskluster 2 AB and a restructuring of the ownership in Bilprovningen

January 25, 2013

Vinge has advised Aktiebolaget Svensk Bilprovning in connection with the restructuring of the ownership in Bilprovningen and the disposal of Besiktningskluster 2 AB to a consortium comprising the twelve minority shareholders in Bilprovningen. Besiktningskluster 2 AB owns around 1/3 of Bilprovningen’s network of inspection stations with a geographic focus in the south-west of Sweden. The restructuring of the ownership in Bilprovningen will result in the Swedish State becoming the sole owner of Bilprovningen. The disposal and restructuring is part of the reregulation and competition exposure of the Swedish vehicle inspection market. The transaction is subject to, inter alia, accreditation approval.

The Vinge team was led by Carl Gustaf De Geer, Daniel Rosvall and Peter Sundgren and included lawyers from a number of practice areas such as M&A, EU &Antitrust, IT, Employment & Benefits, Real Estate, Intellectual Property and also entailed regulatory issues regarding the motor vehicle inspection legislation.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026